Abstract
Background
The aim of this study was to investigate the effects of mind-body therapy on neuroendocrine and cellular immune measures, health-related quality of life and disease activity in patients with ulcerative colitis (UC) in remission.Methods
Thirty UC patients in remission or with low disease activity were randomly assigned to an intervention group (n = 15) or a usual-care waiting control group (n = 15). Intervention consisted of a structured 60-hour training program over 10 weeks which included stress management training, moderate exercise, Mediterranean diet, behavioral techniques and self-care strategies. Quality of life, perceived stress and disease activity were assessed with standardized questionnaires (IBDQ, SF-36, PSS, CAI). In addition, the distribution of circulating lymphocytes and lymphocyte subsets as well as the beta-adrenergic modulation of TNF-alpha production in vitro were analyzed. Urine catecholamines and plasma cortisol, prolactin and growth hormone were measured pre- and postinterventionally, and were compared with a healthy control group (n = 10).Results
In response to therapy, patients in the intervention group showed significantly greater improvement in the SF-36 scale Mental Health and the Psychological Health Sum score compared with changes observed in the usual-care waiting control group. Patients in the intervention group showed significantly greater improvement on the IBDQ scale Bowel Symptoms compared with the control group. However, no significant group differences in circulating lymphocyte subsets or endocrine parameters were observed in response to therapy. In addition, no significant effects of intervention on either the basal levels of TNF-alpha or the suppressive action of the beta-adrenergic agonist isoproterenol on TNF-alpha production were observed.Conclusion
Mind-body therapy may improve quality of life in patients with UC in remission, while no effects of therapy on clinical or physiological parameters were found, which may at least in part be related to selective patient recruitment.References
Articles referenced by this article (57)
Title not supplied
Gastroenterology 1998
Colorectal cancer risk and mortality in patients with ulcerative colitis.
Gastroenterology, (5):1444-1451 1992
MED: 1358741
Survival and causes of death in patients with inflammatory bowel disease: a population-based study.
Gastroenterology, (3):954-960 1992
MED: 1499945
Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease.
Am J Gastroenterol, (6):1822-1830 2001
MED: 11419836
Factors affecting health related quality of life of patients with inflammatory bowel disease.
Qual Life Res, (8):775-781 2002
MED: 12482161
Title not supplied
South Limburg IBD Study Group. Eur J Gastroenterol Hepatol 1996
Janke KH, Raible A, Bauer M, Clemens P, Meisner C, Hauser W, Steder-Neukamm U, Henrich G, Herschbach P, Gregor M, Klump B: Questions on life satisfaction (FLZ(M)) in inflammatory bowel disease. Int J Colorectal Dis 2003.
Impaired health-related quality of life in inflammatory bowel diseases: psychosocial impact and coping styles in a national German sample.
Scand J Gastroenterol, (4):375-382 2001
MED: 11336162
Impact of a nurse-led counselling service on quality of life in patients with inflammatory bowel disease.
J Adv Nurs, (2):152-160 2002
MED: 11940128
Low dominance and high intropunitiveness in ulcerative colitis and irritable bowel syndrome.
Psychother Psychosom, (4):171-176 1986
MED: 3628684
Show 10 more references (10 of 57)
Citations & impact
Impact metrics
Article citations
Participants' perspectives on a multimodal stress management and comprehensive lifestyle modification program for patients with Crohn's disease-A qualitative interview study.
PLoS One, 19(11):e0313127, 13 Nov 2024
Cited by: 0 articles | PMID: 39536026 | PMCID: PMC11559982
What aspects do we overlook in the rehabilitation of patients with inflammatory bowel disease?
World J Gastroenterol, 30(27):3268-3272, 01 Jul 2024
Cited by: 0 articles | PMID: 39086744 | PMCID: PMC11287417
Do interventions for mood improve inflammatory biomarkers in inflammatory bowel disease?: a systematic review and meta-analysis.
EBioMedicine, 100:104910, 24 Jan 2024
Cited by: 5 articles | PMID: 38272759 | PMCID: PMC10878994
Review Free full text in Europe PMC
The IBD-FITT study - moderate-intensity exercise for patients with inflammatory bowel disease with moderate disease activity: an open-label randomized controlled trial.
Trials, 24(1):742, 20 Nov 2023
Cited by: 3 articles | PMID: 37986021 | PMCID: PMC10659067
A systematic review of the effect of structured exercise on inflammation and body composition in inflammatory bowel disease.
Int J Colorectal Dis, 38(1):143, 25 May 2023
Cited by: 3 articles | PMID: 37227593 | PMCID: PMC10212817
Review Free full text in Europe PMC
Go to all (86) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up.
Scand J Gastroenterol, 42(6):734-745, 01 Jun 2007
Cited by: 44 articles | PMID: 17505996
Stress-related peripheral neuroendocrine-immune interactions in women with ulcerative colitis.
Psychoneuroendocrinology, 32(8-10):1086-1096, 01 Sep 2007
Cited by: 19 articles | PMID: 17933470
Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
BMC Gastroenterol, 7:36, 04 Sep 2007
Cited by: 40 articles | PMID: 17784949 | PMCID: PMC1995200
A review of infliximab use in ulcerative colitis.
Clin Ther, 30(2):223-230, 01 Feb 2008
Cited by: 35 articles | PMID: 18343261
Review